- Home
- WAI vs LPCN Comparison
WAI vs LPCN Comparison
Compare WAI & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- LPCN
- Stock Information
- Founded
- WAI 2018
- LPCN 1997
- Country
- WAI China
- LPCN United States
- Employees
- WAI N/A
- LPCN N/A
- Industry
- WAI
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- WAI
- LPCN Health Care
- Exchange
- WAI NYSE
- LPCN Nasdaq
- Market Cap
- WAI 14.8M
- LPCN 16.1M
- IPO Year
- WAI 2023
- LPCN N/A
- Fundamental
- Price
- WAI $3.44
- LPCN $3.29
- Analyst Decision
- WAI
- LPCN Strong Buy
- Analyst Count
- WAI 0
- LPCN 2
- Target Price
- WAI N/A
- LPCN $9.00
- AVG Volume (30 Days)
- WAI 673.2K
- LPCN 59.4K
- Earning Date
- WAI 08-24-2025
- LPCN 08-07-2025
- Dividend Yield
- WAI N/A
- LPCN N/A
- EPS Growth
- WAI N/A
- LPCN N/A
- EPS
- WAI N/A
- LPCN N/A
- Revenue
- WAI $3,750,352.00
- LPCN $3,674,834.00
- Revenue This Year
- WAI N/A
- LPCN N/A
- Revenue Next Year
- WAI N/A
- LPCN N/A
- P/E Ratio
- WAI N/A
- LPCN N/A
- Revenue Growth
- WAI N/A
- LPCN N/A
- 52 Week Low
- WAI $1.38
- LPCN $2.68
- 52 Week High
- WAI $20.00
- LPCN $8.71
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- LPCN 51.52
- Support Level
- WAI N/A
- LPCN $3.13
- Resistance Level
- WAI N/A
- LPCN $3.53
- Average True Range (ATR)
- WAI 0.00
- LPCN 0.24
- MACD
- WAI 0.00
- LPCN 0.01
- Stochastic Oscillator
- WAI 0.00
- LPCN 48.33
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.